RECRUITING

Effect of Abdominal Wall Injections on Abdominal Pain

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This is a prospective cohort study of outpatient adults with chronic abdominal wall pain receiving abdominal wall injections, as part of their usual care, with lidocaine. Subjects will be recruited at the outpatient gastroenterology clinic at OHSU.

Official Title

Effect of Abdominal Wall Injections on Abdominal Pain

Quick Facts

Study Start:2023-01-01
Study Completion:2025-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06121466

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 100 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Localized abdominal wall pain
  2. * Average daily pain (7-day recall) ≥ 3 on a scale of 0-10
  3. * Suspected abdominal wall etiology for abdominal pain
  4. * Positive Carnett's sign or pain near an incisional site
  5. * 18 years of age or older
  1. * Suspected visceral etiology for the abdominal pain
  2. * Severe allergy to lidocaine
  3. * Unwillingness or inability to provide informed consent
  4. * Low probability of follow-up
  5. * Abdominal wall hernia noted at the point of pain
  6. * History of trigger point injections for abdominal pain
  7. * Bleeding disorder
  8. * Pregnancy, incarceration or decisionally impaired

Contacts and Locations

Study Contact

Sophia Lichenstein-Hill, DNP
CONTACT
5038801235
lichenst@ohsu.edu

Study Locations (Sites)

OHSU
Portland, Oregon, 97239
United States
Oregon Health Sciences University
Portland, Oregon, 97239
United States

Collaborators and Investigators

Sponsor: Oregon Health and Science University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-01-01
Study Completion Date2025-12

Study Record Updates

Study Start Date2023-01-01
Study Completion Date2025-12

Terms related to this study

Additional Relevant MeSH Terms

  • Anterior Cutaneous Nerve Entrapment Syndrome